Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantis U.S. Equity ETF (NY:AVUS)

110.94 +0.90 (+0.82%)
Streaming Delayed Price Updated: 12:44 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avantis U.S. Equity ETF

< Previous 1 2 3 Next >
CVS Health CFO Says Company Maintaining Prudent View On Medical Cost Trends Through Remainder Of Year
The firm now expects full-year adjusted earnings per share of $6.30 to $6.40, up from its previous guidance of $6.00 to $6.20. 
Via Stocktwits
Topics Artificial Intelligence Earnings Workforce
Humana Stock Gains On Upbeat Earnings And Raised Guidance, Drawing Retail Praise And UnitedHealth Contrasts
Via Stocktwits
Lucid Signs Up Timothée Chalamet As Global Brand Ambassador: Retail Terms It A Desperate Cash-Draining Move
Chalamet will headline Lucid’s new marketing campaign for its Gravity SUV later this year. 
Via Stocktwits
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’
Via Stocktwits
Centene Reports Unexpected Q2 Loss: But Retail Expects Stock To Close Higher
Via Stocktwits
Lucid Collaborates With 4 Critical Mineral Producers To Strengthen Supply Chain: Retail Deems It A ‘Comeback’
Lucid has joined forces with Alaska Energy Metals, Graphite One, Electric Metals, and RecycLiCo. 
Via Stocktwits
Topics Artificial Intelligence Supply Chain
Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here's What Investors Are Thinking
Via Stocktwits
Autoliv Draws Retail Cheer As CEO Says Company Recovered Significant Portion Of Tariff Costs From Customers In Q2
Via Stocktwits
Humana To Slash Red Tape Around Prior Authorization For Care Services By 2026: Retail Remains Optimistic
Humana CEO Jim Rechtin said that the current healthcare system is “too complex, frustrating, and difficult to navigate” while emphasising the need to “do better.” 
Via Stocktwits
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said. 
Via Stocktwits
Topics Artificial Intelligence
Rivian CEO Transfers Portion Of Holdings In EV Maker To Ex-Wife As Part Of Divorce Settlement
Via Stocktwits
Rivian Stock Slides After Guggenheim Downgrade, But Retail’s Not Pessimistic Yet
Guggenheim cited softer long-term R2/R3 assumptions driven by softer R1 sales, negative U.S. electric vehicle and emissions policy changes as the reasons for the downgrade. 
Via Stocktwits
Topics Electric Vehicles Emissions Government
CMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says Analysts
Via Stocktwits
Ford Recalls Over 850,000 Vehicles In US Over Engine Stalling Concerns
The low-pressure fuel pump in the vehicles may fail, causing a lack of fuel delivery to the engine and resulting in an engine stall while driving, NHTSA said. 
Via Stocktwits
Topics Product Recall
Intuitive Surgical Gets FDA Clearance For Advanced Energy Surgical Instrument: Retail Sentiment Improves
Vessel Sealer Curved is a fully wristed, advanced bipolar electrosurgical instrument designed to seal, cut, grasp, and dissect tissue for use with Intuitive’s da Vinci surgical systems. 
Via Stocktwits
Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older
The vaccine was previously available for pediatric populations under Emergency Use Authorization only. 
Via Stocktwits
Medtronic Names CFO For New Diabetes Company Ahead Of Intended Spin-Off
Chad Spooner’s appointment will be effective July 14, and he will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives. 
Via Stocktwits
Molina Gets A Price Target Cut After Slashing Full-Year Guidance: Retail Sentiment Slips Marginally
The analyst kept an ‘Underperform’ rating on the shares, as per TheFly. 
Via Stocktwits
Topics Artificial Intelligence Government
Baxter Appoints Andrew Hider To Succeed Jose Almeida As CEO: Retail Sentiment Falters
Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), Baxter said. 
Via Stocktwits
Health Insurer Molina Lowers Full Year Earnings Guidance Over Higher Medical Costs Across Industry
For the second quarter (Q2) of 2025, the company now expects adjusted earnings of $5.50 per share, below a mean analyst estimate of $6.21, according to data from Fiscal AI. 
Via Stocktwits
Topics Artificial Intelligence
Regeneron’s Therapy For Blood Cancer Bags FDA Approval: REGN Stock Jumps
While Lynozyfic was granted accelerated approval based on response rate in the LINKER-MM1 trial, continued approval may depend upon verification and description of clinical benefit in a confirmatory... 
Via Stocktwits
Topics Death
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results
Organon said that the mid-stage study evaluating its OG-6219 in endometriosis-related pain did not demonstrate improvement in moderate-to-severe endometriosis-related overall pelvic pain compared to... 
Via Stocktwits
Rivian Stock Slides After Sales Slump In Q2, Despite $1B Equity Boost From Volkswagen
Rivian said production was limited during the quarter in preparation for model year 2026 vehicles, which are expected to launch later in July. 
Via Stocktwits
Ford US Sales Surge 14% In Q2 Despite EV Slump: Pickup Trucks, SUVs Drive Demand
The company’s truck sales jumped 11% in the three months through the end of June to 342,761 units, thanks to increased demand for the F-series, Ranger, and Maverick. 
Via Stocktwits
Topics Electric Vehicles
Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trial
The data is key to receiving approvals for both the individual vaccine candidate and the company’s seasonal flu-COVID combination vaccine candidate. 
Via Stocktwits
BioCryst To Sell European Business Of Its Hereditary Angioedema Drug To Pay Off Debt: Stock Rises While Retail Stays Bearish
As per the terms of the agreement, Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to Orladeyo and the company will also be eligible to receive up... 
Via Stocktwits
AT&T Gains FCC Approval to Replace Copper Lines With Wireless Tech
AT&T (T) gets FCC approval to replace old copper home phone lines with wireless technology, expanding 5G network and fiber coverage for growth. 
Via Benzinga
3 ETFs to Buy Now for High Returns and Low Risk
These three ETFs to buy now try have delivered solid risk-adjusted returns to investors over the long haul. 
Via InvestorPlace
ETF Battles: Which Value Equity ETF Is The Winner?
An audience-requested quadruple header between 4 value equity ETFs from American Century, Charles Schwab, State Street Global Advisors, and Vanguard. 
Via Talk Markets
ETF Battles: Which Broad Stock Market ETF Is Best?
An audience-requested contest between broad stock market ETFs from American Century, State Street Global Advisors, and Vanguard. 
Via Talk Markets
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.